Literature DB >> 5636632

Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients.

S H Curry, J H Marshall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5636632     DOI: 10.1016/0024-3205(68)90356-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  11 in total

1.  Measurement of plasma levels of tricylic psychoactive drugs and their metabolites by UV reflectance photometry of thin layer chromatograms.

Authors:  U Breyer; K Villumsen
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 2.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

3.  Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.

Authors:  T Kolakowska; D H Wiles; M G Gelder; A S McNeilly
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

4.  Hepatic and extrahepatic metabolism of the psychotropic drugs, chlorpromazine, imipramine, and imipramine-N-oxide.

Authors:  R Minder; F Schnetzer; M H Bickel
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  Toxicological data on phenothiazine drugs in autopsy cases.

Authors:  R Bonnichsen; P Geertinger; A C Maehly
Journal:  Z Rechtsmed       Date:  1970

6.  Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.

Authors:  S H Curry
Journal:  Proc R Soc Med       Date:  1971-03

7.  Pharmacology of chlorpromazine: clinical studies.

Authors:  S H Curray; M H Lader; G P Mould; G Sakalis
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

8.  Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.

Authors:  B Szukalski; B Lipska; L Welbel; K Nurowska
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.

Authors:  S Loga; S Curry; M Lader
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

10.  Smoking and body weight influence the clearance of chlorpromazine.

Authors:  M Chetty; R Miller; S V Moodley
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.